104 related articles for article (PubMed ID: 12861051)
21. Cloning and characterization of p10, an alternatively spliced form of p15 cyclin-dependent kinase inhibitor.
Tsubari M; Tiihonen E; Laiho M
Cancer Res; 1997 Jul; 57(14):2966-73. PubMed ID: 9230210
[TBL] [Abstract][Full Text] [Related]
22. Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.
Huang ZY; Baldwin RL; Hedrick NM; Gutmann DH
Oncogene; 2002 Feb; 21(9):1325-34. PubMed ID: 11857076
[TBL] [Abstract][Full Text] [Related]
23. Cyclin-dependent kinases regulate the antiproliferative function of Smads.
Matsuura I; Denissova NG; Wang G; He D; Long J; Liu F
Nature; 2004 Jul; 430(6996):226-31. PubMed ID: 15241418
[TBL] [Abstract][Full Text] [Related]
24. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines.
Timmermann S; Hinds PW; Münger K
Cell Growth Differ; 1997 Apr; 8(4):361-70. PubMed ID: 9101082
[TBL] [Abstract][Full Text] [Related]
25. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15.
Iavarone A; Massagué J
Nature; 1997 May; 387(6631):417-22. PubMed ID: 9163429
[TBL] [Abstract][Full Text] [Related]
26. Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition.
Zhang F; Taipale M; Heiskanen A; Laiho M
Oncogene; 2001 Sep; 20(41):5888-96. PubMed ID: 11593394
[TBL] [Abstract][Full Text] [Related]
27. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
Upton JW; van Dyk LF; Speck SH
Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
[TBL] [Abstract][Full Text] [Related]
28. Increased G1 cyclin/cdk activity in cells overexpressing the candidate oncogene, MCT-1.
Dierov J; Prosniak M; Gallia G; Gartenhaus RB
J Cell Biochem; 1999 Sep; 74(4):544-50. PubMed ID: 10440924
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
Yu B; Lane ME; Pestell RG; Albanese C; Wadler S
Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757
[TBL] [Abstract][Full Text] [Related]
30. Complex regulation of CDKs and G1 arrest during the granulocytic differentiation of human myeloblastic leukemia ML-1 cells.
Shimizu T; Awai N; Takeda K
Oncogene; 2000 Sep; 19(40):4640-6. PubMed ID: 11030153
[TBL] [Abstract][Full Text] [Related]
31. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
[TBL] [Abstract][Full Text] [Related]
32. Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.
Takaki T; Fukasawa K; Suzuki-Takahashi I; Semba K; Kitagawa M; Taya Y; Hirai H
J Biochem; 2005 Mar; 137(3):381-6. PubMed ID: 15809340
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
[TBL] [Abstract][Full Text] [Related]
35. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.
Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A
Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827
[TBL] [Abstract][Full Text] [Related]
36. Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase.
Wang QM; Luo X; Kheir A; Coffman FD; Studzinski GP
Oncogene; 1998 May; 16(21):2729-37. PubMed ID: 9652739
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
Iwanaga R; Ohtani K; Hayashi T; Nakamura M
Oncogene; 2001 Apr; 20(17):2055-67. PubMed ID: 11360190
[TBL] [Abstract][Full Text] [Related]
38. CDK6 blocks differentiation: coupling cell proliferation to the block to differentiation in leukemic cells.
Matushansky I; Radparvar F; Skoultchi AI
Oncogene; 2003 Jul; 22(27):4143-9. PubMed ID: 12833137
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of Cdk6 expression through p38 MAP kinase is involved in differentiation of mouse prechondrocyte ATDC5.
Moro T; Ogasawara T; Chikuda H; Ikeda T; Ogata N; Maruyama Z; Komori T; Hoshi K; Chung UI; Nakamura K; Okayama H; Kawaguchi H
J Cell Physiol; 2005 Sep; 204(3):927-33. PubMed ID: 15795936
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic stimulation recruits cyclin-dependent kinase in the cell cycle start in rat fibroblast.
Jinno S; Hung SC; Yamamoto H; Lin J; Nagata A; Okayama H
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13197-202. PubMed ID: 10557297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
